Stay updated with breaking news from Primary Sclerosing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment Solutions RESEARCH…
PSC Partners and PSC Partners Canada, both patient-led non-profit organizations supporting education and research in primary sclerosing cholangitis (PSC), announced today the enrollment of the first patient into the WIND-PSC study. PSC is a rare...
SOUTH SAN FRANCISCO, Calif., May 21, 2024 -- Pliant Therapeutics, Inc. , a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment...
Sclerosing cholangitis is a liver disease characterized by inflammation and scarring of bile ducts within and outside the liver resulting in their constriction.
(MENAFN - GlobeNewsWire - Nasdaq) -European Patent Office Grants New Patent Covering Use of CM-101 for the Treatment of Multiple Liver Diseases including Primary Sclerosing Cholangitis- -Further ... ...